Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

34 results about "HpaII" patented technology

HpaII (IntEnz: EC 3.1.21.4) is a restriction enzyme obtained from the microorganism called Haemophilus parainfluenzae. It is a DNA restriction enzyme, therefore it has the ability to cut the DNA from certain region as demonstrated below. It has the ability to produce cohesive ends, which are rather useful in constructing plasmids.

Construction method and fermenting method of antibiotic-resistance-free recombinant bacillus subtilis for expressing glutamate decarboxylase

The invention relates to a construction method and a fermenting method of antibiotic-resistance-free recombinant bacillus subtilis for expressing glutamate decarboxylase and belongs to the technical field of bioengineering. The construction method includes taking bacillus subtilis WB600 as an original strain, and knocking out a D-alanine racemase gene on a chromosome of the bacillus subtilis WB600 so as to obtain D-alanine deficient WB600 (dal); fusing an optimized gad gene with an antibiotic-resistance-free expression vector pUB110 (a antibiotics resistance gene is replaced by the D-alanine racemase gene) through an overlap extension PCR technology to obtain a polymer, transforming the polymer into competence of the bacillus subtilis WB600, and enabling the polymer to recombine in a host so as to obtain a recombinant plasmid Pub-HpaII-P43-gad-dal, which is named as bacillus subtilis SK44.001 with the preservation number being CCTCC NO:M 2016774. The fermentation liquor enzyme activity of the antibiotic-resistance-free recombinant bacillus subtilis can be up to 8.6 U/mL, and accordingly the antibiotic-resistance-free recombinant bacillus subtilis has significant industrial application value.
Owner:JIANGNAN UNIV

Application of bactericidal/permeability-increasing protein gene in serving as common disease resistance genetic marker of pigs

The invention relates to a genetic marker for screening the combined gene model of the fourth and tenth exon variation sites of a common disease resistance BPI (bactericidal / permeability increasing protein) gene of pigs, and belongs to the technical fields of genetic breeding and molecular marker assisted selection of pigs. The method comprises the following steps of: extracting DNA (deoxyribonucleic acid) of a pig genome of a sample to be tested, and performing PCR (polymerase chain reaction) amplification on the pig genome; analyzing the PCR product of the exon 4 through SSCP (single strand conformation polymorphism), and performing enzyme digestion on the PCR product of the exon 10 through restriction enzyme HpaII, wherein when the gene model of the pig body to be tested is a CDAB model, the pig body is strong in common disease resistance. According to the application, a molecular genetic marker with higher efficiency and accuracy is provided to molecular marker assisted selection of the pig disease resistance breeding work, and an effective molecular marker breeding means is provided for improving the common disease resistance and immune response capability of piglets. The detection method is simple in operation, low in cost and high in accuracy, can realize automatic direct detection, and takes a magnificent effect in pig breeding.
Owner:YANGZHOU UNIV

Application of bactericidal/permeability-increasing protein gene in serving as common disease resistance genetic marker of pigs

The invention relates to a genetic marker for screening the combined gene model of the fourth and tenth exon variation sites of a common disease resistance BPI (bactericidal / permeability increasing protein) gene of pigs, and belongs to the technical fields of genetic breeding and molecular marker assisted selection of pigs. The method comprises the following steps of: extracting DNA (deoxyribonucleic acid) of a pig genome of a sample to be tested, and performing PCR (polymerase chain reaction) amplification on the pig genome; analyzing the PCR product of the exon 4 through SSCP (single strand conformation polymorphism), and performing enzyme digestion on the PCR product of the exon 10 through restriction enzyme HpaII, wherein when the gene model of the pig body to be tested is a CDAB model, the pig body is strong in common disease resistance. According to the application, a molecular genetic marker with higher efficiency and accuracy is provided to molecular marker assisted selection of the pig disease resistance breeding work, and an effective molecular marker breeding means is provided for improving the common disease resistance and immune response capability of piglets. The detection method is simple in operation, low in cost and high in accuracy, can realize automatic direct detection, and takes a magnificent effect in pig breeding.
Owner:YANGZHOU UNIV

Method for enhancing 2,3-butanediol synthesis by improving intracellular coenzyme level

ActiveCN105154456AReduce the accumulation of acetoinIncrease productivityBacteriaMicroorganism based processesBacillus amyloliquefaciensAcetoin reductase
The last step of synthesis of 2,3-butanediol is that acetoin reductase performs catalytic reduction on acetoin, 2,3-butanediol is synthesized, the reaction requires participation of reduced coenzyme NADH (nicotinamide adenine dinucleotide hydrogen), and thus the high-low level of intracellular coenzyme NADH is an important factor affecting conversion of acetoin to 2,3-butanediol. In order to further improve the synthesis capability of strain 2,3-butanediol and reduce accumulation of byproduct acetoin, HpaII-fdh fragments are inserted into a gene nox, a fragment nox::HpaII-fdh is obtained and guided into bacillus amyloliquefaciens B10-127, and recombinant bacillus amyloliquefaciens (renamed as N delta F) with the fdh gene inserted into the gene nox on a genome is obtained in a homologous recombination principle. Fermentation performance detection of 2,3-butanediol is performed on original bacteria and recombinant bacteria N delta F. A result proves that by comparison with the original bacteria, the yield of the recombinant bacteria 2,3-butanediol is improved by 18.9%, and the yield of the byproduct acetoin is reduced by 70.8%. Accordingly, by means of the strategy, the yield of 2,3-butanediol can be improved, and accumulation of the byproduct acetoin can be reduced.
Owner:JIANGNAN UNIV +1

A method for enhancing the synthesis of 2,3-butanediol by increasing the level of intracellular coenzyme

The last step of synthesis of 2,3-butanediol is that acetoin reductase performs catalytic reduction on acetoin, 2,3-butanediol is synthesized, the reaction requires participation of reduced coenzyme NADH (nicotinamide adenine dinucleotide hydrogen), and thus the high-low level of intracellular coenzyme NADH is an important factor affecting conversion of acetoin to 2,3-butanediol. In order to further improve the synthesis capability of strain 2,3-butanediol and reduce accumulation of byproduct acetoin, HpaII-fdh fragments are inserted into a gene nox, a fragment nox::HpaII-fdh is obtained and guided into bacillus amyloliquefaciens B10-127, and recombinant bacillus amyloliquefaciens (renamed as N delta F) with the fdh gene inserted into the gene nox on a genome is obtained in a homologous recombination principle. Fermentation performance detection of 2,3-butanediol is performed on original bacteria and recombinant bacteria N delta F. A result proves that by comparison with the original bacteria, the yield of the recombinant bacteria 2,3-butanediol is improved by 18.9%, and the yield of the byproduct acetoin is reduced by 70.8%. Accordingly, by means of the strategy, the yield of 2,3-butanediol can be improved, and accumulation of the byproduct acetoin can be reduced.
Owner:JIANGNAN UNIV +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products